By Giulia Petroni

Fresenius SE & Co. KGaA's shares fell on Tuesday after the company released guidance for the current year and provided details on its mid-term targets during the 2021 results report.

At 0846 GMT, shares traded 6% lower at EUR34.38.

The German healthcare company increased its savings target to at least EUR150 million a year in 2023 from over EUR100 million previously. However, it expects organic net profit growth at the bottom end of the 5%-9% compound annual growth rate during the 2020-23 period, which, according to Jefferies, could signal potential pressures.

Analysts at the bank expect the market to focus on guidance as full-year results came in mostly in line with expectations.

Write to Giulia Petroni at giulia.petroni@wsj.com

(END) Dow Jones Newswires

February 22, 2022 04:12 ET (09:12 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.